Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

Revenues for METROPOLIS are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 1.17500
forwardPE 42.79193
debtToEquity 15.29500
earningsGrowth -0.19700
revenueGrowth 0.04300
grossMargins 0.77241
operatingMargins 0.10135
trailingEps 28.20000
forwardEps 0.00000

METROPOLIS's current ratio of 1.175, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as METROPOLIS has enough cash and current assets to handle its immediate liabilities comfortably.
METROPOLIS's low Debt-to-Equity ratio demonstrates that the company maintains a healthy balance between equity and debt, avoiding over-leverage. This suggests a low-risk financial profile, giving investors confidence in the company's stability and ability to manage its financial commitments.
METROPOLIS's low growth in earnings and revenue points to a likely reduction in profits. This signals a weakening financial performance, indicating the company might face difficulties in staying profitable.
METROPOLIS's negative gross and operating margins indicate that the company is unable to generate profit from its core business activities. This suggests financial strain and could be a sign of deeper cost management issues.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

The price of METROPOLIS has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


METROPOLIS experienced 2 selling transactions, with market price of 2095.9249267578125.During the period under review, no sell transactions were recorded.METROPOLIS has seen more buys than sells at its current price levels, which may suggest optimism among investors. This buying trend could indicate that the market expects a favorable performance for the stock in the near future.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Analysts have maintained a buy bias for METROPOLIS, which could prompt investors to consider the stock as a viable investment. With this positive outlook, METROPOLIS is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.